Tat-bh4 and Tat-bcl-xl Peptides Protect Against Sepsis-induced Lymphocyte Apoptosis in Vivo.
From: Department of Anesthesiology, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA. hotchkir@msnotes.wustl.edu
Journal of immunology (Baltimore, Md. : 1950)
- Publish Date: May 2006
- ISSN: 0022-1767
- Volume: 176
- Issue: 9
- Pages: 5471-7
- Medium: Print
- Language: English
- Citation (JAMA): Hotchkiss Richard S, McConnell Kevin W, Bullok Kristin, et al. Tat-bh4 and Tat-bcl-xl Peptides Protect Against Sepsis-induced Lymphocyte Apoptosis in Vivo.. J. Immunol. May 2006;176:5471-7
Abstract
Apoptosis is a key pathogenic mechanism in sepsis that induces extensive death of lymphocytes and dendritic cells, thereby contributing to the immunosuppression that characterizes the septic disorder. Numerous animal studies indicate that prevention of apoptosis in sepsis improves survival and may represent a potential therapy for this highly lethal disorder. Recently, novel cell-penetrating peptide constructs such as HIV-1 TAT basic domain and related peptides have been developed to deliver bioactive cargoes and peptides into cells. In the present study, we investigated the effects of sepsis-induced apoptosis in Bcl-x(L) transgenic mice and in wild-type mice treated with an antiapoptotic TAT-Bcl-x(L) fusion protein and TAT-BH4 peptide. Lymphocytes from Bcl-x(L) transgenic mice were resistant to sepsis-induced apoptosis, and these mice had a approximately 3-fold improvement in survival. TAT-Bcl-x(L) and TAT-BH4 prevented Escherichia coli-induced human lymphocyte apoptosis ex vivo and markedly decreased lymphocyte apoptosis in an in vivo mouse model of sepsis. In conclusion, TAT-conjugated antiapoptotic Bcl-2-like peptides may offer a novel therapy to prevent apoptosis in sepsis and improve survival.
Mesh Headings (Keywords): Animals, Apoptosis, Cells, Cultured, Escherichia coli, Gene Expression Regulation, Gene Products, tat, Humans, Lymphocytes, Male, Mice, Microscopy, Confocal, Peptide Fragments, Proto-Oncogene Proteins, Sepsis, Survival Rate, bcl-X Protein
Check for Full Text / PubMed Unique Identifier (PMID): 16622015
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.